Astrana Health Inc. (ASTH) Stock

About Astrana Health Inc.

Astrana Health Inc. (ASTH) stock trades at $37.45 with a market capitalization of $1.86B. The stock is valued at a price-to-earnings (P/E) ratio of 42.98, price-to-book of 2.10, price-to-sales of 0.46. Over the past 52 weeks the stock has ranged between $18.08 and $51.60, and currently trades 27.4% below its 52-week high.

On profitability, Astrana Health Inc. generates a return on equity (ROE) of 5.09%, return on capital employed of 6.55%, an operating margin of 2.47%, a net profit margin of 1.05%.

Astrana Health Inc. by the numbers, 2015–2025

Between 2015 and 2025 Astrana Health Inc. reported revenue of $44.0M rising to $3.2B, a change of +7131.8% across 10 years. Compounded, revenue has grown 53.8% a year over five years, 40.6% over three, 56.4% over the last twelve months. Net profit rose to $22.0M.

Operating margin went from -14.9% in 2015 to 2.5% in 2025, a gain of 17.4 percentage points. The most recent net margin is 1.05%. On a trailing twelve-month basis to Jun '26, revenue is $3.8B and net profit $40.0M.

Borrowings stand at $1.1B, cash from operations was $115.0M in the latest year, positive in 9 of the last 10.

Return on equity has averaged 8.5% over five years, and was 2.8% in the most recent year.

The share price itself has compounded at 4.6% a year over five years, 5.2% over three, 36.7% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Astrana Health Inc. (ASTH) — frequently asked questions